Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  United Therapeutics Corporation    UTHR

Delayed Quote. Delayed  - 05/27 09:59:59 pm
117.78 USD   +0.54%
05/14 UNITED THERAPEU : For transgender CEO, fight to repeal NC's HB2 is p..
05/13 UNITED THERAPEU : Partnering Deals and Alliances 2010 to 2016; New R..
05/11 UNITED THERAPEU : Steadymed Provides Corporate Update And Reports Fi..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo United Therapeutics Corpor
Develops pharmaceutical products

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening cardiovascular and infectious diseases and cancer.

The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Number of employees : 750 persons.
Sales per Businesses
20142015Delta
USD (in Million)%USD (in Million)%
Pharmaceutical1,289100%1,466100% +13.76%
Sales per Regions
20142015Delta
USD (in Million)%USD (in Million)%
United States1,18191.6%1,35392.3% +14.59%
Rest-of-World107.768.4%112.767.7% +4.64%
Managers
NameAgeSinceTitle
Martine A. Rothblatt PhD, MBA611996Chairman & Co-Chief Executive Officer
Roger A. Jeffs, PhD551998President, Co-Chief Executive Officer & Director
David Zaccardelli, PhD512004Chief Operating Officer & Executive Vice President
James Christopher Edgemond482013Chief Financial Officer & Treasurer
Raymond C. Kurzweil, PhD672002Independent Director
Louis Wade Sullivan, MD812013Independent Director
Raymond Allen Dwek732002Non-Independent Director
Christopher Patusky512002Vice Chairman
Christopher Causey, MBA522003Independent Director
Richard Giltner512009Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 68,828,264 43,885,831 63.8% 24,206,276 35.2% 63.8%
Shareholders
NameEquities%
Fidelity Management & Research Co. 4,444,198 9.96%
Scopia Capital Management LP 4,219,281 9.46%
BlackRock Fund Advisors 3,702,119 8.30%
The Vanguard Group, Inc. 3,564,384 7.99%
AJO LP 1,882,610 4.22%
SSgA Funds Management, Inc. 1,846,710 4.14%
Palo Alto Investors LLC 1,525,654 3.42%
AQR Capital Management LLC 1,306,847 2.93%
LSV Asset Management 1,179,950 2.64%
Deutsche Asset Management Investment GmbH 1,110,374 2.49%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
INCYTE CORPORATIO..
CELLTRION, INC.
LONZA GROUP AG
QUINTILES TRANSNA..
ALKERMES PLC
ALNYLAM PHARMACEU..
SEATTLE GENETICS,..
UNITED THERAPEUTI..
QIAGEN NV
ANACOR PHARMACEUT..
BIO-TECHNE CORP
CHARLES RIVER LAB..
ACADIA PHARMACEUT..
ICON PLC
INTREXON CORP
PAREXEL INTERNATI..
BB BIOTECH AG
-
PRA HEALTH SCIENC..
IONIS PHARMACEUTI..
GALAPAGOS
Sector Biotechnology & Medical Research
United Therapeutics Corpor : Connections
Medical Learning Co., Inc.
University of Oxford
FatKat, Inc.
Kurzweil Technologies, Inc.
Synthetic Genomics, Inc.
Patusky Associates LLC
Project HOPE-The-People-To-People HealthFoundation, Inc.
America's Public Television Stations
X PRIZE Foundation
Google, Inc.
Morehouse School of Medicine
The Sullivan Alliance
Oxford Glycobiology Institute
Public Broadcasting Atlanta
Slater Run Vineyards LLC
The National Health Museum
Causey Consortium
Company contact information
United Therapeutics Corp.
1040 Spring Street
Silver Spring, MD 20910

Phone : +1.301.608.9292
Fax : +1.301.608.9291
Web : www.unither.com
© 2016 People , Fundamentals and Ownership